PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 2900533

  • 1. CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis.
    Kaye WH, Rubinow D, Gwirtsman HE, George DT, Jimerson DC, Gold PW.
    Psychoneuroendocrinology; 1988; 13(3):265-72. PubMed ID: 2900533
    [Abstract] [Full Text] [Related]

  • 2. Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia.
    Gwirtsman HE, Kaye WH, George DT, Jimerson DC, Ebert MH, Gold PW.
    Arch Gen Psychiatry; 1989 Jan; 46(1):61-9. PubMed ID: 2535925
    [Abstract] [Full Text] [Related]

  • 3. Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia.
    Walsh BT, Roose SP, Katz JL, Dyrenfurth I, Wright L, Vande Wiele R, Glassman AH.
    Psychoneuroendocrinology; 1987 Jan; 12(2):131-40. PubMed ID: 3037583
    [Abstract] [Full Text] [Related]

  • 4. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
    Kling MA, Rubinow DR, Doran AR, Roy A, Davis CL, Calabrese JR, Nieman LK, Post RM, Chrousos GP, Gold PW.
    Neuroendocrinology; 1993 Jan; 57(1):79-88. PubMed ID: 8097579
    [Abstract] [Full Text] [Related]

  • 5. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression.
    Kaye WH, Gwirtsman HE, George DT, Ebert MH, Jimerson DC, Tomai TP, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):203-8. PubMed ID: 3491830
    [Abstract] [Full Text] [Related]

  • 6. CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations.
    Demitrack MA, Lesem MD, Listwak SJ, Brandt HA, Jimerson DC, Gold PW.
    Am J Psychiatry; 1990 Jul; 147(7):882-6. PubMed ID: 2356873
    [Abstract] [Full Text] [Related]

  • 7. Disturbances in the hypothalamo-pituitary-adrenal and other neuroendocrine axes in bulimia.
    Fichter MM, Pirke KM, Pöllinger J, Wolfram G, Brunner E.
    Biol Psychiatry; 1990 May 01; 27(9):1021-37. PubMed ID: 2110485
    [Abstract] [Full Text] [Related]

  • 8. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I, Bissette G, Dettling M, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Nemeroff CB, Holsboer F.
    Depress Anxiety; 1998 May 01; 8(2):71-9. PubMed ID: 9784981
    [Abstract] [Full Text] [Related]

  • 9. Thyrotropin, prolactin, and growth hormone responses to thyrotropin-releasing hormone in anorexia nervosa and bulimia.
    Kiriike N, Nishiwaki S, Izumiya Y, Maeda Y, Kawakita Y.
    Biol Psychiatry; 1987 Feb 01; 22(2):167-76. PubMed ID: 3101755
    [Abstract] [Full Text] [Related]

  • 10. Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa.
    Frank GK, Kaye WH, Ladenheim EE, McConaha C.
    Appetite; 2001 Aug 01; 37(1):9-14. PubMed ID: 11562153
    [Abstract] [Full Text] [Related]

  • 11. The dexamethasone-suppressed corticotrophin-releasing hormone stimulation test in anorexia nervosa.
    Duclos M, Corcuff JB, Roger P, Tabarin A.
    Clin Endocrinol (Oxf); 1999 Dec 01; 51(6):725-31. PubMed ID: 10619977
    [Abstract] [Full Text] [Related]

  • 12. The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients.
    Hotta M, Shibasaki T, Masuda A, Imaki T, Demura H, Ling N, Shizume K.
    J Clin Endocrinol Metab; 1986 Feb 01; 62(2):319-24. PubMed ID: 3001125
    [Abstract] [Full Text] [Related]

  • 13. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
    J Psychiatr Res; 2007 Feb 01; 41(1-2):131-43. PubMed ID: 16455105
    [Abstract] [Full Text] [Related]

  • 14. Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa.
    Kaye WH, Berrettini WH, Gwirtsman HE, Chretien M, Gold PW, George DT, Jimerson DC, Ebert MH.
    Life Sci; 1987 Nov 02; 41(18):2147-55. PubMed ID: 2823041
    [Abstract] [Full Text] [Related]

  • 15. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G, Mathé AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P.
    Psychopharmacology (Berl); 2005 Oct 02; 181(4):751-60. PubMed ID: 15988572
    [Abstract] [Full Text] [Related]

  • 16. Bulimia nervosa--a primary defect in the hypothalamic-pituitary-adrenal axis?
    Birketvedt GS, Drivenes E, Agledahl I, Sundsfjord J, Olstad R, Florholmen JR.
    Appetite; 2006 Mar 02; 46(2):164-7. PubMed ID: 16499999
    [Abstract] [Full Text] [Related]

  • 17. Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients.
    Widerlöv E, Bissette G, Nemeroff CB.
    J Affect Disord; 1988 Mar 02; 14(2):99-107. PubMed ID: 2452842
    [Abstract] [Full Text] [Related]

  • 18. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients.
    Gold PW, Gwirtsman H, Avgerinos PC, Nieman LK, Gallucci WT, Kaye W, Jimerson D, Ebert M, Rittmaster R, Loriaux DL.
    N Engl J Med; 1986 May 22; 314(21):1335-42. PubMed ID: 3010109
    [Abstract] [Full Text] [Related]

  • 19. Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol.
    Putignano P, Dubini A, Toja P, Invitti C, Bonfanti S, Redaelli G, Zappulli D, Cavagnini F.
    Eur J Endocrinol; 2001 Aug 22; 145(2):165-71. PubMed ID: 11454512
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone.
    Vythilingam M, Anderson GM, Owens MJ, Halaszynski TM, Bremner JD, Carpenter LL, Heninger GR, Nemeroff CB, Charney DS.
    J Clin Endocrinol Metab; 2000 Nov 22; 85(11):4138-45. PubMed ID: 11095445
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.